These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10737164)

  • 1. Treatment modalities in comparison: when do clinical differences emerge?
    Locatelli F; Manzoni C
    Nephrol Dial Transplant; 2000; 15 Suppl 1():29-35. PubMed ID: 10737164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility in haemodialysis: fact and fiction.
    Locatelli F; Manzoni C
    Curr Opin Nephrol Hypertens; 1997 Nov; 6(6):528-32. PubMed ID: 9375265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-line monitoring and convective treatment modalities: short-term advantages.
    Locatelli F; Manzoni C; Di Filippo S; Andrulli S
    Nephrol Dial Transplant; 1999; 14 Suppl 3():92-7. PubMed ID: 10382988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of convective transport.
    Locatelli F; Manzoni C; Di Filippo S
    Kidney Int Suppl; 2002 May; (80):115-20. PubMed ID: 11982825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of membranes on morbidity.
    Locatelli F
    Nephrol Dial Transplant; 1996; 11 Suppl 2():116-20. PubMed ID: 8804010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of convection on the nutritional status of haemodialysis patients.
    Basile C
    Nephrol Dial Transplant; 2003 Aug; 18 Suppl 7():vii46-9; discussion vii58-9. PubMed ID: 12953030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study.
    Basile C; Giordano R; Montanaro A; De Maio PD; De Padova FD; Marangi AL; Semeraro A
    Nephrol Dial Transplant; 2001 Sep; 16(9):1914-9. PubMed ID: 11522879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation.
    Klingel R; Schaefer M; Schwarting A; Himmelsbach F; Altes U; Uhlenbusch-Körwer I; Hafner G
    Nephrol Dial Transplant; 2004 Jan; 19(1):164-70. PubMed ID: 14671052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study.
    Wizemann V; Lotz C; Techert F; Uthoff S
    Nephrol Dial Transplant; 2000; 15 Suppl 1():43-8. PubMed ID: 10737166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis adequacy and response to erythropoietic agents: what is the evidence base?
    Locatelli F; Del Vecchio L
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii29-35. PubMed ID: 14607998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of the high-performance membrane dialyzer.
    Koda Y
    Contrib Nephrol; 2011; 173():58-69. PubMed ID: 21865777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the clinical condition of haemodialysis patients.
    Locatelli F; Manzoni C; Del Vecchio L; Di Filippo S
    J Nephrol; 1999; 12 Suppl 2():S82-91. PubMed ID: 10688406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.
    De Vriese AS; Langlois M; Bernard D; Geerolf I; Stevens L; Boelaert JR; Schurgers M; Matthys E
    Nephrol Dial Transplant; 2003 Dec; 18(12):2596-600. PubMed ID: 14605283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study.
    Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL; Vincent JL; Tielemans C
    Nephrol Dial Transplant; 2000 Feb; 15(2):224-30. PubMed ID: 10648669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress.
    Kosch M; Levers A; Fobker M; Barenbrock M; Schaefer RM; Rahn KH; Hausberg M
    Nephrol Dial Transplant; 2003 Jul; 18(7):1370-5. PubMed ID: 12808175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients.
    Wanner C; Bahner U; Mattern R; Lang D; Passlick-Deetjen J
    Nephrol Dial Transplant; 2004 Oct; 19(10):2570-5. PubMed ID: 15280524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux.
    Schiffl H; Fischer R; Lang SM; Mangel E
    Nephrol Dial Transplant; 2000 Jun; 15(6):840-5. PubMed ID: 10831638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.